Nkarta Stock (NASDAQ: NKTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 697.91K |
Day Range | - - - |
52 Wk Range | 1.28 - 16.24 |
Market Cap | $366.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 15.69% |
Days to Cover | 19.05 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.
Other companies in Nkarta’s space includes: Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Anika Therapeutics (NASDAQ:ANIK) and Monte Rosa Therapeutics (NASDAQ:GLUE).
Nkarta has a consensus price target of $24.00.
The stock price for Nkarta (NASDAQ: NKTX) is $5.2 last updated September 20, 2024 at 4:16 PM EDT.
There are no upcoming dividends for Nkarta.
Nkarta’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Nkarta.
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.